Clinical outcomes of de novo metastatic HER2-low breast cancer: a National Cancer Database Analysis.
Saved in:
| Title: | Clinical outcomes of de novo metastatic HER2-low breast cancer: a National Cancer Database Analysis. |
|---|---|
| Authors: | Jiang C; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Changchuanjiang@gmail.com., Perimbeti S; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Deng L; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Shapiro CL; Division of Hematology and Medical Oncology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Gandhi S; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA. Shipra.Gandhi@roswellpark.org. |
| Source: | NPJ breast cancer [NPJ Breast Cancer] 2022 Dec 30; Vol. 8 (1), pp. 135. Date of Electronic Publication: 2022 Dec 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
